fbpx

Check out the latest episodes of our Life Science and Food Industry Podcasts. Available everywhere!

X

FDA Issues Safety Warning for Blood Cancer Drug + Long COVID Risk Assessment Tool – Xtalks Life Science Podcast Ep. 68

FDA Issues Safety Warning for Blood Cancer Drug + Long COVID Risk Assessment Tool – Xtalks Life Science Podcast Ep. 68

In this episode, Ayesha talked about a safety warning issued by the US Food and Drug Administration (FDA) for Secura Bio’s Copiktra (duvelisib), which is a drug used to treat adults with relapsed or refractory chronic lymphocytic leukemia (CLL) and small lymphocytic leukemia (SLL). The FDA flagged the drug after evaluating long-term survival data, which showed that the drug was associated with a higher risk of serious side effects and a possibly increased risk of death.

Ayesha also talked about a new nuclear magnetic resonance (NMR)-based molecular research tool for the assessment of the risk of Long COVID, including multi-organ damage and cardiovascular disease risk. The phenomics tool is being developed by Bruker for research purposes and is based on well-characterized metabolic and proteomic biomarkers associated with Long COVID. Hear more about the tool and how it can help patients receive appropriate treatment interventions early for Long COVID.

Listen on Apple Podcasts

Read the full articles here:

Copiktra Blood Cancer Drug Gets FDA Warning Due to Increased Risk of Serious Side Effects and Death

Bruker Develops New Tool for Assessing Long COVID Risk

The weekly podcast is available for streaming every Wednesday on SpotifyApple Music and wherever you stream your podcasts.

Subscribe to the Xtalks Life Science Podcast to never miss a new episode.